MedTrace Logo

Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor

NCT04894682 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-03-17

No results posted yet for this study

Summary

The objective of this study is to assess the inoculation-related symptoms and long-term effects of COVID-19 vaccines in patients with lung cancer or pulmonary nodules in a real-world setting. The investigators aim to provide high-quality evidence for the COVID-19 vaccines in cancer/pre-cancer patients, and to address their concern about the safety profile of the newly developed vaccines.

Conditions

  • Lung Cancer
  • Pulmonary Nodule, Solitary
  • Pulmonary Nodule, Multiple
  • COVID-19 Pneumonia
  • Vaccine Adverse Reaction
  • SARS-CoV-2 Acute Respiratory Disease

Interventions

BIOLOGICAL

Vaccine inoculation against SARS-CoV-2

Inoculation with any type of approved vaccines according to the standard or recommended dose

Sponsors & Collaborators

  • Guangdong Provincial People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2021-08-31
Completion
2022-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04894682 on ClinicalTrials.gov